Full List Of Stories
Gilead Sciences to test inhaled version of Covid-19 treatment, Remdesivir
US biotechnology giant Gilead Sciences will start testing an inhaled version of its treatment for Covid-19, Remdesivir, in August.
Europe close: Stocks end moderately lower, Covid-19 outbreaks in focus
Stocks on the Continent finished lower on Monday but off their worst levels of the session as investors monitored news of higher Covid-19 case counts in the US, Germany, India and also China.
Europe midday: Stocks drift lower amid rising Covid-19 infections
Stocks on the Continent have turned lower but remain will off their lows of the session with investors apparently brushing off news of higher Covid-19 cases in the US, Germany and even China.
Tuesday preview: Global manufacturing and services surveys in focus
The market spotlight on Tuesday will be on a raft of closely-followed activity surveys for manufacturing and services around the world, with those for the Eurozone and the UK expected to show a sharp improvement in June as lockdown measures have been eased.
German judge, finance minister see scope to resolve dispute between Constitutional Court and ECB
An incoming new judge to Germany's Constitutional Court signalled optimism that the dispute with the European Central Bank over the latter's bond buying programme could be resolved.
US existing home sales fall more quickly than expected in May
Second-hand home sales fell more quickly than expected last month but analysts pointed to various data points, including falling mortgage rates, that augured a rebound in coming month.
France to cut shortest-haul air routes in favour of rail
'Normality' in short-haul travel in the euro area's second-largest economy will be redefined as a result of the Covid-19 pandemic.
BofA stays at 'underperform' on Asos, cites long-term margin concerns
Analysts at Bank of America hiked their target price for shares of Asos, judging that consensus was overlooking the "strong" short-term outlook for the online retailer's sales.